For investigators
Information for investigators around trial design, criteria and outcomes.
![PROPHESY-2 trial logo](https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/32755/prophesy-2-logo.png)
The PROPHESY-2 trial will assess whether prothrombin complex concentrate is superior to fresh frozen plasma with respect to a composite of mortality, organ failure or infection up to and including 90 days from randomisation in adult patients who are actively bleeding within 24 hours of their cardiac surgery.